CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, is scheduled to participate in the Wachovia 2008 Healthcare Conference on Wednesday, January 30, 2008 in Boston.
